Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factor

Details for Australian Patent Application No. 2004268017 (hide)

International Classifications

Event Publications

23 March 2006 PCT application entered the National Phase

PCT publication WO2005/020919 Priority application(s): WO2005/020919

30 March 2006 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 08 Mar 2006

25 May 2006 Section 223 Application Received

Board of Regents The University of Texas System; Cytokine PharmaSciences, Inc. An application to extend the time from 09 Mar 2005 to 09 Apr 2006 in which to comply with Section 6(c) has been filed . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2005

20 July 2006 Section 223 Application Allowed

Board of Regents The University of Texas System; Cytokine PharmaSciences, Inc. The time in which to comply with Section 6(c) has been extended to 09 Apr 2006. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2005

17 March 2011 Application Accepted

Published as AU-B-2004268017

14 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.